Reproducibility of pulmonary function tests in patients with systemic sclerosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 11 2023
Historique:
received: 22 01 2023
accepted: 25 10 2023
medline: 6 11 2023
pubmed: 4 11 2023
entrez: 4 11 2023
Statut: epublish

Résumé

Systemic sclerosis (SSc) is a rare autoimmune disease in which interstitial lung disease (ILD) is the leading cause of morbidity and mortality. Clinical management of the lung disease is mainly based on pulmonary function testing (PFT) and their changes over time. Little is known about the reproducibility of PFT testing in SSc patients. The aim of this study was to assess the test-retest reliability and reproducibility of PFTs in SSc patients with or without ILD over 30 days in order determine the potential physiologic variation over the time. We performed prospective observational study of SSc patients. The FVC, FEV1/FVC ratio, DLCO and KCO parameters were assessed in this population at four different timepoints; T0 (time 0) and H3 (T0 + 3 h) defined test-retest reliability, D15 (T0 + 15 days) and D30 (T0 + 30 days) for reproducibility. A mixed linear model was used to test the effect of time (and therefore reproducibility) on patients and we looked for an interaction. We included 25 SSc patients divided in two groups, 14 with ILD and 11 non-ILD. Interactions between time and group were not significant and were not reported. Time and group did not significantly influence the different measures of the PFT: FVC [p values time and group effect respectively (0.33; 0.34)], FEV1/FVC ratio (0.093; 0.056) and DLCO (0.99; 0.13) in the ILD and non ILD group (Table S2). The analyse with interactions between time and group were not significant and are not reported. We also used a Bland Altman test to assess reproducibility for FVC (L) and DLCO (mMKpa/min/L), Figs. 1 and 2 respectively. The measurements were therefore reproducible over time and in each group. PFT parameters are reproducible over time in a clinically stable population of SSc (no significant effect of the time T0, H3, D15 and D30) and there is no significant distinction between patients with ILD and no ILD. These respiratory functional data can further underline their use in clinical practice.

Identifiants

pubmed: 37923803
doi: 10.1038/s41598-023-45881-y
pii: 10.1038/s41598-023-45881-y
pmc: PMC10624913
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18960

Informations de copyright

© 2023. The Author(s).

Références

J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Open Access Rheumatol. 2019 Dec 09;11:283-307
pubmed: 31849543
Sci Rep. 2022 Mar 28;12(1):5289
pubmed: 35347225
Nat Rev Rheumatol. 2023 Apr;19(4):212-226
pubmed: 36849541
Clin Rev Allergy Immunol. 2023 Jun;64(3):262-283
pubmed: 34487318
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Diagnostics (Basel). 2023 Feb 23;13(5):
pubmed: 36899995
Rheumatology (Oxford). 2019 Sep 1;58(9):1534-1546
pubmed: 31292645
Sci Rep. 2021 May 25;11(1):10882
pubmed: 34035374
Chest. 2003 Apr;123(4):1090-5
pubmed: 12684298
Rheumatol Int. 2019 Aug;39(8):1369-1376
pubmed: 31056725
Front Pharmacol. 2019 Apr 16;10:360
pubmed: 31073287
Respir Physiol Neurobiol. 2017 Dec;246:33-38
pubmed: 28782664
Sci Rep. 2021 May 21;11(1):10679
pubmed: 34021175
Am J Respir Crit Care Med. 2004 Jan 15;169(2):235-8
pubmed: 14604836
J Rheumatol. 2001 Jul;28(7):1573-6
pubmed: 11469464
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54
pubmed: 18369202
RMD Open. 2023 Feb;9(1):
pubmed: 36813476
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v65-7
pubmed: 18784151
Respir Res. 2005 Aug 17;6:96
pubmed: 16107215
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
Clin Epigenetics. 2020 Aug 17;12(1):124
pubmed: 32807242
Respir Res. 2022 Sep 21;23(1):262
pubmed: 36131305
Arthritis Rheum. 2000 Feb;43(2):444-51
pubmed: 10693887
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1304-45
pubmed: 17545458
N Engl J Med. 2019 Oct 31;381(18):1718-1727
pubmed: 31566307

Auteurs

P Jacquerie (P)

Rheumatology Department, CHU LiègeULiège, Domaine Universitaire Sart Tilman, B35, 4020, Liège, Belgium. pjacquerie@chuliege.be.

B André (B)

Rheumatology Department, CHU LiègeULiège, Domaine Universitaire Sart Tilman, B35, 4020, Liège, Belgium.

D De Seny (D)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

M Henket (M)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

L Giltay (L)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

M Ernst (M)

Biostatistics and Research Method Center (B-STAT), ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

R Louis (R)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

M Malaise (M)

Rheumatology Department, CHU LiègeULiège, Domaine Universitaire Sart Tilman, B35, 4020, Liège, Belgium.

C Ribbens (C)

Rheumatology Department, CHU LiègeULiège, Domaine Universitaire Sart Tilman, B35, 4020, Liège, Belgium.

J Guiot (J)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH